Xanomeline (LY-246,708; Lumeron, Memcor) is a small molecule muscarinic acetylcholine receptor agonist that was first synthesized in a collaboration between...
16 KB (1,497 words) - 14:55, 2 October 2024
Xanomeline/trospium chloride, sold under the brand name Cobenfy, is a fixed-dose combination medication used for the treatment of schizophrenia. It contains...
16 KB (1,436 words) - 01:50, 2 October 2024
promising. The dual M1, M4 agonist xanomeline has been proposed as a potential treatment for schizophrenia. Xanomeline/trospium chloride was approved in...
9 KB (844 words) - 07:33, 30 September 2024
consumption is associated with weaker symptoms. It inspired the development of xanomeline (see § Drugs below). It enhances learning and memory in rodents. AN (Areca...
23 KB (2,331 words) - 12:09, 3 October 2024
long-term adherence to treatment. The fixed-dose combination medication xanomeline/trospium chloride (Cobenfy) was approved for medical use in the United...
172 KB (18,780 words) - 19:46, 27 September 2024
Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide...
59 KB (5,263 words) - 07:28, 28 September 2024
Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide...
239 KB (24,668 words) - 23:04, 3 October 2024
Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide...
34 KB (3,196 words) - 06:07, 15 August 2024
asset, KarXT, an investigational muscarinic antipsychotic combination of Xanomeline and Trospium. In November 2023, the FDA accepted Karuna Therapeutics'...
96 KB (7,620 words) - 18:19, 2 October 2024
Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide...
41 KB (4,364 words) - 04:26, 27 September 2024